Skip to Content

Gentaur Nivolumab – Anti-PD-1 Antibody

https://www.kineret-eu.com/web/image/product.template/26251/image_1920?unique=58978df
(0 review)
A research-grade biosimilar to nivolumab, targeting PD-1. Used in tumor immunology, TIL analysis, and immune modulation.

1,234,567.00 € 1234567.0 EUR 1,234,567.00 € Tax Excluded

1,234,567.00 € Tax Excluded

Not Available For Sale

(0.00 € / Units)

    This combination does not exist.

    Terms and Conditions
    30-day money-back guarantee
    Shipping: 2-3 Business Days


    Internal Reference: GMA-PD-1
    Display Name: [GMA-PD-1] Gentaur Nivolumab – Anti-PD-1 Antibody